Board of Directors
Tricia Mullins has worked for over twenty years in the biotech space in rare and chronic conditions. Tricia has held instrumental senior leadership roles in patient advocacy, sales, marketing, KOL engagement and new business development creating global programs and platforms in orphan diseases, chronic diseases and conditions critical to public health priorities. Tricia has extensive strategic and advocacy experience with ten biotech launches, four in orphan diseases. Tricia holds a Bachelor of Science degree from St. John’s University and is currently pursuing her Masters in Public Health.Tricia’s passion is patients. She brings solutions to biotech industry partners, community organizations, patient organizations, patients and their families.